Patent · US Active

Method of treating or prevention of atherothrombotic events in patients with history of myocardial infarction

US10300065B2 · kind B2 · utility

0Cited by
0References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 27, 2016
Grant dateMay 28, 2019
Priority date
Expiry dateJan 27, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to methods for reducing the rate of cardiovascular death, myocardial infarction, or stroke in a patient in recognized need thereof, comprising administering to the patient a pharmaceutical composition comprising 60 mg ticagrelor twice daily.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.